Results 291 to 300 of about 776,222 (355)

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén   +16 more
wiley   +1 more source

Changes in Body Image and Pain in Patients with Cushing Syndrome: A Predictor for Depression and Vice Versa. [PDF]

open access: yesJ Endocr Soc
Bednarski F   +10 more
europepmc   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer   +25 more
wiley   +1 more source

ESEH Conference Munich 2013

open access: yesHistoria Ambiental Latinoamericana y Caribeña, 2013
Eunice Sueli Nodari
doaj   +2 more sources

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion. [PDF]

open access: yesBlood Adv
Rohrbacher L   +20 more
europepmc   +1 more source

Memantine treatment in individuals with GRIN gain‐of‐function variants is associated with improvements in behavior, development, and seizure frequency

open access: yesEpilepsia, EarlyView.
Abstract Objective GRIN‐related disorders due to pathogenic variants in GRIN1, GRIN2A, GRIN2B, or GRIN2D genes are associated with altered N‐methyl‐D‐aspartate receptor (NMDAR) function. Functional changes include gain (GoF) and loss of receptor function (LoF). Clinical reports describing the use of the NMDAR blocker memantine in GRIN‐related disorders
Maike Karnstedt   +17 more
wiley   +1 more source

A rare case of secondary paroxysmal hemicrania caused by a T1 nerve root schwannoma. [PDF]

open access: yesPain Rep
Zwergal RM   +4 more
europepmc   +1 more source

Microcirculatory impairment and increased arterial stiffness in pediatric Long COVID patients. [PDF]

open access: yesEur J Pediatr
Boever J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy